RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, ...

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

Today on AirTalk, an update on COVID-19 funding and the latest on the future of vaccination efforts, the American Society of ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

In a new episode of the video series STATus Report, a closer look at the reasons health secretary RFK Jr. cited for canceling contracts on mRNA vaccine research.

Exosomes, naturally derived vesicles responsible for intercellular communication, are emerging as next-generation drug ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

Jay Bhattacharya is director of the National Institutes of Health.